P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.
Maynard JP, Lu J, Vidal I, Hicks J, Mummert L, Ali T, Kempski R, Carter AM, Sosa RY, Peiffer LB, Joshu CE, Lotan TL, De Marzo AM, Sfanos KS.
Maynard JP, et al. Among authors: peiffer lb.
J Pathol. 2022 Feb;256(2):149-163. doi: 10.1002/path.5815. Epub 2021 Nov 25.
J Pathol. 2022.
PMID: 34652816
Free PMC article.